Ariel Precision Medicine

Ariel Precision Medicine has developed decision-support tools that integrate complex genetics into clinical decision making to enable earlier diagnosis and targeted management for complex chronic digestive and metabolic diseases. By leveraging genetic information, AI, and clinical inputs, Ariel creates a “risk profile” for patients to help clinicians better understand what is driving a patient’s condition, allowing them to focus on treating the biological disease drivers rather than the physical symptoms. With an initial focus on pancreatitis and an expanding product line, Ariel’s platform is currently in the market and being used by over 250 physicians across 120 institutions.